Clinical Value of PTEN in Patients with Superficial Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|80|3|264-269

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.80, Iss.3, 2008-05, pp. : 264-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standard versus Hydrophilic Catheterization in the Adjuvant Treatment of Patients with Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 73, Iss. 1, 2008-06 ,pp. : 19-22

Karger

Access to resources Recommend Favorite

Differential PTEN Protein Expression Profiles in Superficial versus Invasive Bladder Cancers

By  

Urologia Internationalis, Vol. 75, Iss. 2, 2008-07 ,pp. : 102-106

Karger

Access to resources Recommend Favorite

Determination of a New Cut-Off Value for the Urinary BTAtrak to Optimize the Detection of Recurrences in the Follow-Up of Patients with Superficial Bladder Carcinoma

By  

Current Urology, Vol. 1, Iss. 1, 2007-09 ,pp. : 42-47

Karger

Access to resources Recommend Favorite

Significance of Protein p53 Overexpression in the Clinical Course of High-Risk Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 3, 2003-04 ,pp. : 172-177

Karger

Access to resources Recommend Favorite

Autoimmune Clinical Manifestations following Intravesical Bacillus Calmette-Guérin and Interferon alpha 2b Immunotherapy for Superficial Bladder Cancer

By  

Current Urology, Vol. 3, Iss. 1, 2009-05 ,pp. : 36-40

Karger

Access to resources Recommend Favorite